MedTrace Logo

DETOUR I Clinical Study for Percutaneous Femoropopliteal Bypass

NCT02471638 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 78

Last updated 2025-05-23

Study results available
· View outcomes & findings →

Summary

To assess the safety and performance of the PQ Bypass System to access, deliver guidewires and implant stent grafts for a percutaneous fem-pop bypass.

Conditions

  • Peripheral Arterial Disease

Interventions

DEVICE

PQ Bypass System for Femoropopliteal Bypass

To access, deliver guidewires and implant stent grafts for a percutaneous fem-pop bypass.

Sponsors & Collaborators

  • Endologix

    lead INDUSTRY

Principal Investigators

  • Dierk Scheinert, PhD · University of Leipzig

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2018-09-30
Completion
2020-06-30
FDA Device
Yes

Countries

  • Chile
  • Germany
  • Italy
  • Latvia
  • New Zealand
  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02471638 on ClinicalTrials.gov